Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Illumina, Inc. (ILMN) News - StockMarketCap

Stocks›Illumina, Inc.☆

● At closeAs of Jul 2, 2026

Illumina, Inc.

ILMN✓

HealthcareMedical - Diagnostics & ResearchNASDAQ

$188.68+2.60%

$28.55BMarket cap

31.74xP/E ratio

2.92MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$188.68

$4.79 (+2.60%) · 24h

Key metrics

Market cap$28.55B+6.95%

Enterprise value$28.06B

Volume (24h)2.92M

P/E ratio (TTM)31.74x

P/S ratio (TTM)6.06x

Dividend yield0.00%

Shares outstanding151.30M

Trading range

Previous close$183.89

Day range$184.40 - $189.36

52-week range$88.00 - $182.84

Illumina, Inc. (ILMN) operates in the Medical - Diagnostics & Research industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news